By Kelcee Griffis ( January 26, 2017, 5:44 PM EST) -- The Federal Circuit Thursday ruled Mylan Institutional LLC infringed Tennessee drugmaker Cumberland Pharmaceuticals Inc.'s patent for the overdose treatment Acetadote with its application for a generic, affirming that Cumberland's formula was not based on suggestions from the U.S. Food and Drug Administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.